Robert J. Durso

1.1k total citations
14 papers, 915 citations indexed

About

Robert J. Durso is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Robert J. Durso has authored 14 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Epidemiology and 5 papers in Immunology. Recurrent topics in Robert J. Durso's work include Immunotherapy and Immune Responses (5 papers), Hepatitis C virus research (4 papers) and Hepatitis B Virus Studies (3 papers). Robert J. Durso is often cited by papers focused on Immunotherapy and Immune Responses (5 papers), Hepatitis C virus research (4 papers) and Hepatitis B Virus Studies (3 papers). Robert J. Durso collaborates with scholars based in United States, Canada and Belgium. Robert J. Durso's co-authors include Jason P. Gardner, Tatjana Dragic, William C. Olson, Emmanuel Cormier, Gerald P. Donovan, Paul J. Maddon, Francis Kajumo, Lise Boussemart, Joseph C. Reese and Sofija Andjelić and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Genes & Development.

In The Last Decade

Robert J. Durso

12 papers receiving 846 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert J. Durso United States	10	450	404	253	231	194	14	915
K. Crawford United States	10	956 2.1×	781 1.9×	151 0.6×	284 1.2×	219 1.1×	13	1.4k
Jonas Söderholm Sweden	15	516 1.1×	461 1.1×	315 1.2×	154 0.7×	61 0.3×	28	965
Motoko Nagano‐Fujii Japan	22	846 1.9×	799 2.0×	218 0.9×	314 1.4×	76 0.4×	38	1.3k
Bridget M. Donovan United States	7	320 0.7×	270 0.7×	125 0.5×	91 0.4×	94 0.5×	7	540
Kevin Crawford Canada	12	897 2.0×	688 1.7×	87 0.3×	419 1.8×	322 1.7×	13	1.3k
Sangeetha Vijaysri United States	7	278 0.6×	341 0.8×	194 0.8×	178 0.8×	40 0.2×	7	657
Alessandra Coiana Italy	9	1.0k 2.2×	841 2.1×	124 0.5×	111 0.5×	133 0.7×	24	1.3k
Noboru Maki Japan	18	778 1.7×	889 2.2×	124 0.5×	249 1.1×	70 0.4×	26	1.3k
Carine Logvinoff France	8	1.1k 2.4×	865 2.1×	95 0.4×	162 0.7×	433 2.2×	11	1.3k
Rajiv G. Tawar France	7	256 0.6×	395 1.0×	94 0.4×	112 0.5×	103 0.5×	9	634

Countries citing papers authored by Robert J. Durso

Since Specialization

Citations

This map shows the geographic impact of Robert J. Durso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Durso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Durso more than expected).

Fields of papers citing papers by Robert J. Durso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Durso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Durso. The network helps show where Robert J. Durso may publish in the future.

Co-authorship network of co-authors of Robert J. Durso

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Durso. A scholar is included among the top collaborators of Robert J. Durso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Durso. Robert J. Durso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Groves, Christopher J., Michael A. Linden, Ahmad Al‐Attar, et al.. (2025). Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel—recommendations and safeguards for clinical laboratories. Cytometry Part B Clinical Cytometry. 110(1). 11–21.

Monaghan, Sara A., Steven Eck, Silvia T. Bunting, et al.. (2024). Flow cytometry assay modifications: Recommendations for method validation based on CLSI H62 guidelines. Cytometry Part B Clinical Cytometry. 108(3). 252–266. 3 indexed citations

Slovin, Susan F., Robert J. Durso, William C. Olson, et al.. (2012). A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in subjects with prostate cancer. Vaccine. 31(6). 943–949. 64 indexed citations

Durso, Robert J., Tracy Curley, Robert J. Israel, et al.. (2011). A phase I dose escalation trial of vaccine replicon particles (VRP) expressing prostate-specific membrane antigen (PSMA) in patients (pts) with castration-resistant prostate cancer (CRPC): Preliminary results.. Journal of Clinical Oncology. 29(7_suppl). 140–140.

Banerjee, Kaustuv, Sofija Andjelić, Per Johan Klasse, et al.. (2009). Enzymatic removal of mannose moieties can increase the immune response to HIV-1 gp120 in vivo. Virology. 389(1-2). 108–121. 45 indexed citations

Kang, Yun, Sofija Andjelić, James Μ. Binley, et al.. (2009). Structural and immunogenicity studies of a cleaved, stabilized envelope trimer derived from subtype A HIV-1. Vaccine. 27(37). 5120–5132. 52 indexed citations

Durso, Robert J., Sofija Andjelić, Jason P. Gardner, et al.. (2007). A Novel Alphavirus Vaccine Encoding Prostate-Specific Membrane Antigen Elicits Potent Cellular and Humoral Immune Responses. Clinical Cancer Research. 13(13). 3999–4008. 56 indexed citations

Falkowska, Emilia, Robert J. Durso, Jason P. Gardner, et al.. (2006). L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles. Journal of General Virology. 87(9). 2571–2576. 9 indexed citations

Gardner, Jason P., Robert J. Durso, Maureen F. Maughan, et al.. (2005). Novel prime-boost combinations of PSMA-based vaccines for prostate cancer. Journal of Clinical Oncology. 23(16_suppl). 2572–2572. 2 indexed citations

10.

Cormier, Emmanuel, et al.. (2004). CD81 is an entry coreceptor for hepatitis C virus. Proceedings of the National Academy of Sciences. 101(19). 7270–7274. 232 indexed citations

11.

Cormier, Emmanuel, Robert J. Durso, Lise Boussemart, et al.. (2004). L-SIGN (CD209L) and DC-SIGN (CD209) mediate transinfection of liver cells by hepatitis C virus. Proceedings of the National Academy of Sciences. 101(39). 14067–14072. 160 indexed citations

12.

Gardner, Jason P., Robert J. Durso, Gerald P. Donovan, et al.. (2003). L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proceedings of the National Academy of Sciences. 100(8). 4498–4503. 227 indexed citations

13.

Stitzel, Michael L., Robert J. Durso, & Joseph C. Reese. (2001). The proteasome regulates the UV-induced activation of the AP-1-like transcription factor Gcn4. Genes & Development. 15(2). 128–133. 30 indexed citations

14.

Durso, Robert J., et al.. (2001). Analysis of TAF90 Mutants Displaying Allele-Specific and Broad Defects in Transcription. Molecular and Cellular Biology. 21(21). 7331–7344. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact